HRP20241171T1 - Pripravak za kontroliranu stimulaciju jajnika - Google Patents
Pripravak za kontroliranu stimulaciju jajnika Download PDFInfo
- Publication number
- HRP20241171T1 HRP20241171T1 HRP20241171TT HRP20241171T HRP20241171T1 HR P20241171 T1 HRP20241171 T1 HR P20241171T1 HR P20241171T T HRP20241171T T HR P20241171TT HR P20241171 T HRP20241171 T HR P20241171T HR P20241171 T1 HRP20241171 T1 HR P20241171T1
- Authority
- HR
- Croatia
- Prior art keywords
- patient
- amh
- preparation
- body weight
- pmol
- Prior art date
Links
- 230000002611 ovarian Effects 0.000 title 1
- 230000000638 stimulation Effects 0.000 title 1
- 230000037396 body weight Effects 0.000 claims 10
- 102000012673 Follicle Stimulating Hormone Human genes 0.000 claims 7
- 108010079345 Follicle Stimulating Hormone Proteins 0.000 claims 7
- 229940028334 follicle stimulating hormone Drugs 0.000 claims 7
- 208000000509 infertility Diseases 0.000 claims 6
- 230000036512 infertility Effects 0.000 claims 6
- 231100000535 infertility Toxicity 0.000 claims 6
- 210000002966 serum Anatomy 0.000 claims 5
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Pregnancy & Childbirth (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17189119 | 2017-09-01 | ||
| EP21196378.0A EP3973982B1 (en) | 2017-09-01 | 2018-08-31 | Composition for controlled ovarian stimulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20241171T1 true HRP20241171T1 (hr) | 2024-11-22 |
Family
ID=59772482
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20241171TT HRP20241171T1 (hr) | 2017-09-01 | 2018-08-31 | Pripravak za kontroliranu stimulaciju jajnika |
| HRP20211802TT HRP20211802T1 (hr) | 2017-09-01 | 2018-08-31 | Pripravak za kontroliranu stimulaciju jajnika |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20211802TT HRP20211802T1 (hr) | 2017-09-01 | 2018-08-31 | Pripravak za kontroliranu stimulaciju jajnika |
Country Status (32)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI846743B (zh) | 2018-10-17 | 2024-07-01 | 荷蘭商菲林公司 | 用於控制性卵巢刺激之組成物及方法 |
| TW202237173A (zh) * | 2020-12-09 | 2022-10-01 | 荷蘭商菲林公司 | 用於受控的卵巢刺激之組成物及方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2217113T5 (es) * | 2000-01-27 | 2008-11-01 | Laboratoires Serono Sa | Uso de fsh para tratar infertilidad. |
| US20040248784A1 (en) | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| ES2494928T3 (es) * | 2007-09-21 | 2014-09-16 | Pharmabrand S.A. | Composición que comprende polisacáridos mucilaginosos derivados de Aloe barbadensis combinados con liposomas, procedimiento para la obtención de los mismos y su uso como protector solar, un agente antiacné, un regenerador epidérmico y un hidratante |
| TWI488640B (zh) | 2008-04-16 | 2015-06-21 | Ferring Int Ct Sa | 藥學製劑 |
| US20130045933A1 (en) * | 2010-01-21 | 2013-02-21 | Ramot At Tel-Aviv University Ltd. | Aloe-emodin derivatives and use thereof for the treatment of cancer |
| RS54214B2 (sr) | 2010-09-29 | 2024-02-29 | Ferring Bv | Smeša za upotrebu u lečenju infertiliteta |
| AR090095A1 (es) | 2011-06-06 | 2014-10-22 | Ferring Bv | Preparacion farmaceutica que comprende hormona estimulante del foliculo recombinante |
| JO3092B1 (ar) | 2011-08-08 | 2017-03-15 | Ferring Bv | مركب لتحفيز مسيطر عليه للمبيض |
| SG11201608132UA (en) * | 2014-04-18 | 2016-11-29 | Glycotope Gmbh | Controlled ovarian hyperstimulation with improved recombinant human follicle-stimulating hormone |
| SI3261661T1 (sl) | 2015-02-26 | 2024-03-29 | Ferring B.V. | Menotropin za zdravljenje neplodnosti |
| PL3662925T3 (pl) * | 2015-04-17 | 2021-10-25 | Ferring B.V. | Kompozycja zawierająca FSH do leczenia niepłodności |
| EA034022B1 (ru) | 2015-04-24 | 2019-12-19 | Ферринг Б.В. | Способ получения гонадотропина |
| JP6845813B2 (ja) | 2015-06-26 | 2021-03-24 | フェリング ベスローテン フェンノートシャップ | 精製および／またはウイルス不活性化の方法 |
| PL3787667T3 (pl) | 2018-04-30 | 2025-07-28 | Ferring B.V. | Kompozycja do kontrolowanej stymulacji jajników |
| TWI846743B (zh) | 2018-10-17 | 2024-07-01 | 荷蘭商菲林公司 | 用於控制性卵巢刺激之組成物及方法 |
-
2018
- 2018-08-31 DK DK21196378.0T patent/DK3973982T3/da active
- 2018-08-31 MA MA56224A patent/MA56224B1/fr unknown
- 2018-08-31 MA MA50034A patent/MA50034B1/fr unknown
- 2018-08-31 LT LTEP21196378.0T patent/LT3973982T/lt unknown
- 2018-08-31 US US16/642,777 patent/US11744879B2/en active Active
- 2018-08-31 EP EP24181981.2A patent/EP4427806A3/en active Pending
- 2018-08-31 SG SG11202003840QA patent/SG11202003840QA/en unknown
- 2018-08-31 ES ES18768795T patent/ES2904787T3/es active Active
- 2018-08-31 LT LTEPPCT/EP2018/073442T patent/LT3675894T/lt unknown
- 2018-08-31 EP EP21196378.0A patent/EP3973982B1/en active Active
- 2018-08-31 KR KR1020207009105A patent/KR20200045543A/ko not_active Ceased
- 2018-08-31 JP JP2020512546A patent/JP6856819B2/ja active Active
- 2018-08-31 TW TW107130683A patent/TWI749255B/zh active
- 2018-08-31 SI SI201830484T patent/SI3675894T1/sl unknown
- 2018-08-31 HU HUE18768795A patent/HUE056726T2/hu unknown
- 2018-08-31 AR ARP180102492 patent/AR112541A1/es unknown
- 2018-08-31 PL PL18768795T patent/PL3675894T3/pl unknown
- 2018-08-31 HR HRP20241171TT patent/HRP20241171T1/hr unknown
- 2018-08-31 BR BR112020003379-0A patent/BR112020003379A2/pt unknown
- 2018-08-31 CN CN201880055934.1A patent/CN111050787A/zh active Pending
- 2018-08-31 IL IL272763A patent/IL272763B2/en unknown
- 2018-08-31 SI SI201831147T patent/SI3973982T1/sl unknown
- 2018-08-31 RS RS20241007A patent/RS65945B1/sr unknown
- 2018-08-31 KR KR1020257016376A patent/KR20250078595A/ko active Pending
- 2018-08-31 AU AU2018326556A patent/AU2018326556B2/en active Active
- 2018-08-31 HR HRP20211802TT patent/HRP20211802T1/hr unknown
- 2018-08-31 FI FIEP21196378.0T patent/FI3973982T3/fi active
- 2018-08-31 MD MDE20200700T patent/MD3675894T2/ro unknown
- 2018-08-31 DK DK18768795.9T patent/DK3675894T3/da active
- 2018-08-31 EA EA202090480A patent/EA202090480A1/ru unknown
- 2018-08-31 PT PT187687959T patent/PT3675894T/pt unknown
- 2018-08-31 WO PCT/EP2018/073442 patent/WO2019043143A1/en not_active Ceased
- 2018-08-31 CA CA3073624A patent/CA3073624A1/en active Pending
- 2018-08-31 PL PL21196378.0T patent/PL3973982T3/pl unknown
- 2018-08-31 JO JOP/2020/0034A patent/JOP20200034A1/ar unknown
- 2018-08-31 UA UAA202002175A patent/UA126869C2/uk unknown
- 2018-08-31 PT PT211963780T patent/PT3973982T/pt unknown
- 2018-08-31 MD MDE20220351T patent/MD3973982T2/ro unknown
- 2018-08-31 MX MX2020002235A patent/MX2020002235A/es unknown
- 2018-08-31 CN CN202510833422.5A patent/CN120617484A/zh active Pending
- 2018-08-31 HU HUE21196378A patent/HUE068024T2/hu unknown
- 2018-08-31 ES ES21196378T patent/ES2989511T3/es active Active
- 2018-08-31 MY MYPI2020000971A patent/MY200791A/en unknown
- 2018-08-31 RS RS20220042A patent/RS62810B1/sr unknown
- 2018-08-31 EP EP18768795.9A patent/EP3675894B1/en active Active
-
2020
- 2020-02-27 CL CL2020000482A patent/CL2020000482A1/es unknown
- 2020-02-27 MX MX2024009224A patent/MX2024009224A/es unknown
- 2020-02-28 PH PH12020500404A patent/PH12020500404A1/en unknown
- 2020-10-30 JP JP2020182295A patent/JP7373479B2/ja active Active
-
2023
- 2023-07-25 US US18/226,206 patent/US20240024424A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20210722T1 (hr) | Pripravak za kontroliranu stimulaciju jajnika | |
| BR112021024137A2 (pt) | Dispositivos e métodos para entrega de dose com precisão | |
| HRP20240013T1 (hr) | Menotropin za liječenje neplodnosti | |
| BR112015018252A2 (pt) | composição farmacêutica aquosa de dose fixa estável para administração nasal para um ser humano, composição de suspensão aquosa farmacêutica de dose fixa estável para administração nasal para um ser humano, suspensão estável adequada para administração nasal a um ser humano, método para tratar rinite em um ser humano necessitando do mesmo, uso da composição farmacêutica para administração nasal, método para liberar uma composição farmacêutica e kit | |
| MY188749A (en) | Compositions comprising a combination of nivolumab and ipilimumab | |
| MX2019010907A (es) | Agonistas del receptor x farnesoide, y usos de los mismos. | |
| BR112014028633A8 (pt) | tratamento de amd usando sflt-1 de aav | |
| BR112017006957A2 (pt) | formulações farmacêuticas para a liberação por via oral de fármacos do tipo de peptídeo ou proteína | |
| PH12021550605A1 (en) | Farnesoid x receptor agonists and uses thereof | |
| JP2018519366A5 (enExample) | ||
| WO2016044839A3 (en) | Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds | |
| FI3229828T3 (fi) | Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio | |
| MX2019014483A (es) | Regimenes de dosificación de antagonistas de hormona liberadora de gonadotropina para el tratamiento de endometriosis. | |
| BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
| BR112019023260A2 (pt) | Fatores de crescimento de fibroblastos recombinantes modificados e seus usos terapêuticos | |
| WO2016191458A3 (en) | Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment | |
| MX2018000546A (es) | Composiciones farmaceuticas que contienen celecoxib y tramadol. | |
| HRP20241171T1 (hr) | Pripravak za kontroliranu stimulaciju jajnika | |
| NZ769954A (en) | Syringe devices for use in an emergency | |
| MX2016014346A (es) | Tratamiento de enfermedad de crohn con 6-mercaptopurina de liberacion prolongada. | |
| BR112018000039A2 (pt) | dispositivo de liberação de uso único | |
| BR112019004210A2 (pt) | composição farmacêutica, método e kit para tratamento da deficiência de hormônio do crescimento | |
| EP4470625A3 (en) | A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting | |
| UA118192C2 (uk) | Противірусна фармацевтична композиція | |
| JP2019529569A5 (enExample) |